The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Antimicrobial peptide mimics for improved therapeutic properties
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Computed circular dichroism spectra for the evaluation of protein conformation
Greenfield, N. J., & Fasman, G. D. (1969) · Biochemistry · doi:10.1021/bi00838a031 · Cited by 3,694
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
Bee and Wasp Venoms: The biochemistry and pharmacology of their peptides and enzymes are reviewed.
Habermann, E. (1972) · Science · doi:10.1126/science.177.4046.314 · Cited by 1,324
Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., & Moos, W. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a076 · Cited by 1,277
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
Mammalian defensins in the antimicrobial immune response
Selsted, M. E., & Ouellette, A. J. (2005) · Nature Immunology · doi:10.1038/ni1206 · Cited by 1,203
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
HULTMARK, D., STEINER, H., RASMUSON, T., & BOMAN, H. G. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb05991.x · Cited by 1,008
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Membrane Pores Induced by Magainin
Ludtke, S. J., He, K., Heller, W. T., Harroun, T. A., Yang, L., & Huang, H. W. (1996) · Biochemistry · doi:10.1021/bi9620621 · Cited by 802
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
All-D amino acid-containing channel-forming antibiotic peptides.
Wade, D., Boman, A., Wåhlin, B., Drain, C. M., Andreu, D., Boman, H. G., & Merrifield, R. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4761 · Cited by 677
Non-haemolytic β-amino-acid oligomers
Porter, E. A., Wang, X., Lee, H.-S., Weisblum, B., & Gellman, S. H. (2000) · Nature · doi:10.1038/35007145 · Cited by 671
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Adessi, C., & Soto, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606731 · Cited by 614
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Park, C. B., Yi, K.-S., Matsuzaki, K., Kim, M. S., & Kim, S. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150518097 · Cited by 546
García-Olmedo, F., Molina, A., Alamillo, J. M., & Rodríguez-Palenzuéla, P. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<479::aid-bip6>3.0.co;2-k · Cited by 523
Christensen, B., Fink, J., Merrifield, R. B., & Mauzerall, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5072 · Cited by 514
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Insect Antimicrobial Peptides: Structures, Properties and Gene Regulation
Bulet, P., & Stocklin, R. (2005) · Protein & Peptide Letters · doi:10.2174/0929866053406011 · Cited by 487
Sequence-specific polypeptoids: A diverse family of heteropolymers with stable secondary structure
Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P., Bradley, E. K., Truong, K. T. V., Dill, K. A., Cohen, F. E., & Zuckermann, R. N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4303 · Cited by 483
Mechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
Antimicrobial Peptides in Action
Leontiadou, H., Mark, A. E., & Marrink, S. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062927q · Cited by 472
De novo design of biomimetic antimicrobial polymers
Tew, G. N., Liu, D., Chen, B., Doerksen, R. J., Kaplan, J., Carroll, P. J., Klein, M. L., & DeGrado, W. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082046199 · Cited by 442
Bacterial resistance to antibiotics: Modified target sites
LAMBERT, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 424
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Shai, Y., & Oren, Z. (2001) · Peptides · doi:10.1016/s0196-9781(01)00498-3 · Cited by 370
Interaction between Heat Shock Proteins and Antimicrobial Peptides
Otvos, O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., & Blaszczyk-Thurin, M. (2000) · Biochemistry · doi:10.1021/bi0012843 · Cited by 370
Experimental evolution of resistance to an antimicrobial peptide
Perron, G. G., Zasloff, M., & Bell, G. (2006) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2005.3301 · Cited by 369
Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides
Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Lehrer, R. I., Welsh, M. J., & Tack, B. F. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2748-2755.2000 · Cited by 369
Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.605-614.2002 · Cited by 354
De Novo Design of Antibacterial β-Peptides
Hamuro, Y., Schneider, J. P., & DeGrado, W. F. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992728p · Cited by 345
De Novo Design, Synthesis, and Characterization of Antimicrobial β-Peptides
Liu, D., & DeGrado, W. F. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0107475 · Cited by 339
Ganz, T. (1999) · Science · doi:10.1126/science.286.5439.420 · Cited by 321
Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers
Miller, S. M., Simon, R. J., Ng, S., Zuckermann, R. N., Kerr, J. M., & Moos, W. H. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80691-0 · Cited by 317
Mor, A., Huong, N. V., Delfour, A., Migliore-Samour, D., & Nicolas, P. (1991) · Biochemistry · doi:10.1021/bi00100a014 · Cited by 313
Self-citationSusceptibility of Phytopathogenic Bacteria to Wheat Purothionins In Vitro
Caleya, R. F. D., Gonzalez-Pascual, B., García‐Olmedo, F., & Carbonero, P. (1972) · Applied Microbiology · doi:10.1128/aem.23.5.998-1000.1972 · Cited by 305
All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance
(1990) · FEBS Letters · doi:10.1016/0014-5793(90)81351-n · Cited by 294
Cationic Antimicrobial Peptides: Issues for Potential Clinical Use
Bradshaw, J. P. (2003) · BioDrugs · doi:10.2165/00063030-200317040-00002 · Cited by 293
Raguse, T. L., Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0270423 · Cited by 283
Mor, A., Hani, K., & Nicolas, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31742-3 · Cited by 279
Self-citationInfectious disease: Connecting innate immunity to biocidal polymers
Gabriel, G. J., Som, A., Madkour, A. E., Eren, T., & Tew, G. N. (2007) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.03.002 · Cited by 264
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Self-citationMimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers
Patch, J. A., & Barron, A. E. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00385-x · Cited by 255
Effects of pH and salinity on the antimicrobial properties of clavanins
Lee, I. H., Cho, Y., & Lehrer, R. I. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2898-2903.1997 · Cited by 254
Wu, C. W., Sanborn, T. J., Huang, K., Zuckermann, R. N., & Barron, A. E. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003154n · Cited by 247
Schmitt, M. A., Weisblum, B., & Gellman, S. H. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048546z · Cited by 232
Friedrich, C. L., Rozek, A., Patrzykat, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009691200 · Cited by 225
Schmitt, M. A., Weisblum, B., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0666553 · Cited by 219
Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides
Lai, X.-Z., Feng, Y., Pollard, J., Chin, J. N., Rybak, M. J., Bucki, R., Epand, R. F., Epand, R. M., & Savage, P. B. (2008) · Accounts of Chemical Research · doi:10.1021/ar700270t · Cited by 214
Nontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352791 · Cited by 211
Therapeutic peptides revisited
Latham, P. W. (1999) · Nature Biotechnology · doi:10.1038/11686 · Cited by 207
Membrane Composition Determines Pardaxin's Mechanism of Lipid Bilayer Disruption
Hallock, K. J., Lee, D.-K., Omnaas, J., Mosberg, H. I., & Ramamoorthy, A. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75226-0 · Cited by 207
Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability,
Rozek, A., Powers, J.-P. S., Friedrich, C. L., & Hancock, R. E. W. (2003) · Biochemistry · doi:10.1021/bi035643g · Cited by 206
Feder, R., Dagan, A., & Mor, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4230 · Cited by 197
Self-citationPorcelli, F., Verardi, R., Shi, L., Henzler-Wildman, K. A., Ramamoorthy, A., & Veglia, G. (2008) · Biochemistry · doi:10.1021/bi702036s · Cited by 189
Isolation and structure of novel defensive peptides from frog skin
MOR, A., & NICOLAS, P. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19924.x · Cited by 187
Self-citationNontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie · doi:10.1002/ange.200352791 · Cited by 184
van Belkum, M. J., Kok, J., Venema, G., Holo, H., Nes, I. F., Konings, W. N., & Abee, T. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.24.7934-7941.1991 · Cited by 180
Bacterial Membranes as Predictors of Antimicrobial Potency
Epand, R. M., Rotem, S., Mor, A., Berno, B., & Epand, R. F. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8062327 · Cited by 172
Self-citationStructure and Orientation of Pardaxin Determined by NMR Experiments in Model Membranes
Porcelli, F., Buck, B., Lee, D.-K., Hallock, K. J., Ramamoorthy, A., & Veglia, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405454200 · Cited by 170
Porcelli, F., Buck-Koehntop, B. A., Thennarasu, S., Ramamoorthy, A., & Veglia, G. (2006) · Biochemistry · doi:10.1021/bi0601813 · Cited by 168
Kustanovich, I., Shalev, D. E., Mikhlin, M., Gaidukov, L., & Mor, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111071200 · Cited by 167
Self-citationBeckloff, N., Laube, D. M., Castro, T. A., Furgang, D., Park, S., Perlin, D. S., Clements, D. J., Tang, H., Scott, R. W., Tew, G. N., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00208-07 · Cited by 161
Retro and retroenantio analogs of cecropin-melittin hybrids.
Merrifield, R. B., Juvvadi, P., Andreu, D., Ubach, J., Boman, A., & Boman, H. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3449 · Cited by 161
Diastereomers of Cytolysins, a Novel Class of Potent Antibacterial Peptides
Shai, Y., & Oren, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7305 · Cited by 160
Synthetic mimics of antimicrobial peptides
Som, A., Vemparala, S., Ivanov, I. N., & Tew, G. N. (2008) · Biopolymers · doi:10.1002/bip.20970 · Cited by 152
Blondelle, S. E., & Lohner, K. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<74::aid-bip70>3.0.co;2-s · Cited by 139
Synthetic Antimicrobial Oligomers Induce a Composition-Dependent Topological Transition in Membranes
Yang, L., Gordon, V. D., Mishra, A., Som, A., Purdy, K. R., Davis, M. A., Tew, G. N., & Wong, G. C. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072310o · Cited by 134
Design of Synthetic Antimicrobial Peptides Based on Sequence Analogy and Amphipathicity
Tossi, A., Tarantino, C., & Romeo, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0549a.x · Cited by 133
D’Agata, E. M. C. (2004) · Infection Control · doi:10.1086/502306 · Cited by 128
Instruments of microbial warfare: Bacteriocin synthesis, toxicity and immunity
Baba, T., & Schneewind, O. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01196-7 · Cited by 123
Antimalarial Activities of Dermaseptin S4 Derivatives
Krugliak, M., Feder, R., Zolotarev, V. Y., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2442-2451.2000 · Cited by 118
Structure, Synthesis, and Molecular Cloning of Dermaseptins B, a Family of Skin Peptide Antibiotics
Charpentier, S., Amiche, M., Mešter, J., Vouille, V., Caër, J. L., Nicolas, P., & Delfour, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14690 · Cited by 111
Antimicrobial activity of an abiotic host defense peptide mimic
Tew, G. N., Clements, D. J., Tang, H., Arnt, L., & Scott, R. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.001 · Cited by 109
Dermaseptin S9, an α-Helical Antimicrobial Peptide with a Hydrophobic Core and Cationic Termini
Lequin, O., Ladram, A., Chabbert, L., Bruston, F., Convert, O., Vanhoye, D., Chassaing, G., Nicolas, P., & Amiche, M. (2005) · Biochemistry · doi:10.1021/bi051711i · Cited by 109
Xiong, Y.-Q., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1111 · Cited by 107
Antibacterial drug discovery in the 21st century
Bush, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1005.x · Cited by 106
Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides
Radzishevsky, I. S., Rotem, S., Zaknoon, F., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2412-2420.2005 · Cited by 98
Self-citationJing, W., Hunter, H. N., Hagel, J., & Vogel, H. J. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.00050.x · Cited by 93
Ishitsuka, Y., Arnt, L., Majewski, J. P., Frey, S. L., Ratajczek, M., Kjær, K., Tew, G. N., & Lee, K. Y. C. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061186q · Cited by 93
In Vitro Antiplasmodium Effects of Dermaseptin S4 Derivatives
Dagan, A., Efron, L., Gaidukov, L., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1059-1066.2002 · Cited by 92
Shaw, J. E., Epand, R. F., Hsu, J. C. Y., Mo, G. C. H., Epand, R. M., & Yip, C. M. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.11.003 · Cited by 85
Biomimetic Facially Amphiphilic Antibacterial Oligomers with Conformationally Stiff Backbones
Tang, H., Doerksen, R. J., Jones, T. V., Klein, M. L., & Tew, G. N. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.02.007 · Cited by 83
Efron, L., Dagan, A., Gaidukov, L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202089200 · Cited by 79
Design of Host Defence Peptides for Antimicrobial and Immunity Enhancing Activities
McPhee, J. B., Scott, M. G., & Hancock, R. E. W. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764558 · Cited by 76
Blondelle, S. E., Pérez‐Payá, E., & Houghten, R. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1067 · Cited by 73
Analogous oligo‐acyl‐lysines with distinct antibacterial mechanisms
Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon‐Venezia, S., Carmeli, Y., & Mor, A. (2008) · The FASEB Journal · doi:10.1096/fj.07-105015 · Cited by 65
Self-citationStructural Consequences of Carboxyamidation of Dermaseptin S3
Shalev, D. E., Mor, A., & Kustanovich, I. M. (2002) · Biochemistry · doi:10.1021/bi016013m · Cited by 63
Self-citationMembrane Lipid Composition and the Interaction of Pardaxin: The Role of Cholesterol
Epand, R. F., Ramamoorthy, A., & Epand, R. M. (2005) · Protein and Peptide Letters · doi:10.2174/092986606774502063 · Cited by 63
Antibacterial Properties of Dermaseptin S4 Derivatives under Extreme Incubation Conditions
Rydlo, T., Rotem, S., & Mor, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.490-497.2006 · Cited by 63
Self-citationStructure-Activity Relationships of Antibacterial Acyl-Lysine Oligomers
Radzishevsky, I. S., Kovachi, T., Porat, Y., Ziserman, L., Zaknoon, F., Danino, D., & Mor, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.006 · Cited by 61
Self-citationImpact of Self-Assembly Properties on Antibacterial Activity of Short Acyl-Lysine Oligomers
Sarig, H., Rotem, S., Ziserman, L., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-08 · Cited by 61
Self-citationAntimicrobial defences in Drosophila: the story so far
Naitza, S., & Ligoxygakis, P. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.008 · Cited by 56
Histatin and lactoferrin derived peptides: Antimicrobial properties and effects on mammalian cells
Stallmann, H. P., Faber, C., Bronckers, A. L. J. J., Hogervorst, J. M. A., Brouwer, C. P. J. M., Amerongen, A. V. N., & Wuisman, P. I. J. M. (2005) · Peptides · doi:10.1016/j.peptides.2005.05.014 · Cited by 54
Patent confusion in law on new plant varieties
Porter, J. R. (2000) · Nature · doi:10.1038/35003742 · Cited by 43
Rotem, S., Radzishevsky, I. S., & Mor, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00030-06 · Cited by 40
Self-citationAntiplasmodial Activity of Lauryl-Lysine Oligomers
Radzishevsky, I. S., Krugliak, M., Ginsburg, H., & Mor, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-06 · Cited by 37
Self-citationShalev, D. E., Rotem, S., Fish, A., & Mor, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513051200 · Cited by 36
Self-citationMarynka, K., Rotem, S., Portnaya, I., Cogan, U., & Mor, A. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.009 · Cited by 28
Self-citationScreening of antipsychotic drugs in animal models
Weiner, I., Gaisler, I., Schiller, D., Green, A., Zuckerman, L., & Joel, D. (2000) · Drug Development Research · doi:10.1002/1098-2299(200007/08)50:3/4<440::aid-ddr27>3.0.co;2-4 · Cited by 26
Generation and utilization of synthetic combinatorial libraries
Eichler, J., & Houghten, R. A. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)91867-1 · Cited by 22
Inhibition of enterocin CRL35 antibiotic activity by mono- and divalent ions
Minahk, C. J., & Morero, R. D. (2003) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2003.01411.x · Cited by 22
Cited by
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
Metadata
- Authors
- Rotem, S., & Mor, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 1788
- Issue
- 8
- Pages
- 1582-1592
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2066275795
- Cited by
- 296
- References
- 123
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.